About: Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) 2000 թվականին հրատարակված գիտական հոդված (hy) wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована в січні 2000 (uk) im Januar 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2000 (ast) научна статија објавена на 01 јануари 2000 (mk) articolo scientifico (pubblicato il 2000) (it) artikull shkencor i botuar më 01 janar 2000 (sq) scientific article published on 01 January 2000 (en)
publication date	wds:Q57571575-EEB97A1F-1016-42B7-86B0-329CD884E20D
publication date	2000-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q57571575-08FCCF5B-8D75-4FF6-B6E3-E1BF875B95A0 wds:Q57571575-1469B63C-63DA-4100-8E14-40424145E71C wds:Q57571575-18316B03-133C-46A9-8B9F-BBEC3AEFB842 wds:Q57571575-2CAC673C-1D70-4DDE-BB9E-E882D121E7AF wds:Q57571575-2E83FE12-131D-46AD-975E-B87018DD8B7D wds:Q57571575-32FCD486-B929-4325-BF78-969128B01CE3 wds:Q57571575-35B7B7CA-CAA8-445E-904E-1E3620CFF6E5 wds:Q57571575-39AA6C16-9FE1-4FEB-8A49-B9B181B4491C wds:Q57571575-572E0AD8-B382-4A8A-9199-410641E88B12 wds:Q57571575-5F22749B-6ACD-4119-A510-D65E67D9D09F wds:Q57571575-7BF52026-881C-4157-9A68-00CC308FEF34 wds:Q57571575-95E5248A-84CC-444C-A572-7D5C0F390D59 wds:Q57571575-98E29230-F5EC-45A1-AEBE-EBBDBF9ECBB6 wds:Q57571575-9C95DAC1-CCCB-4269-A7A4-0288E09F8D1C wds:Q57571575-A0DFF665-79FF-4171-9BFB-954C7BFC6820 wds:Q57571575-A93561D0-D8D5-40FD-9AD5-76C0A0E4271C wds:Q57571575-AA8E0C89-52BF-49B3-A84E-ABAA5CD9C3EC wds:Q57571575-B634E4E0-1B44-4183-85E7-07A4B138976C wds:Q57571575-B9478892-001B-4303-A9D1-99AF76D2C521 wds:Q57571575-C6C0F9D4-39CB-414C-98D2-F052C58FA1E1 wds:Q57571575-D102F94B-E16E-4770-A022-F8A40FA78616 wds:Q57571575-E46ADF2F-C4FB-4B9F-A4AB-D37F25BAB8BA
cites work	High-dose ifosfamide with mesna uroprotection: a phase I study Prognostic factors in soft tissue sarcomas: the Aarhus experience Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS) Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas Nonparametric Estimation from Incomplete Observations Synovial sarcoma. Uniform response of metastases to high dose ifosfamide High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence The importance of dose intensity in chemotherapy of metastatic breast cancer High-dose ifosfamide is associated with severe, reversible cardiac dysfunction Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM). Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible? High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group The management of adult soft tissue sarcomas The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study Pharmacokinetics of ifosfamide administered according to three different schedules in metastatic soft tissue and bone sarcomas The role of adjuvant chemotherapy in the treatment of adult soft tissue sarcomas
author name string	wds:Q57571575-047D859D-8221-40C5-831A-8BEE8E661F1F wds:Q57571575-103D735D-56B2-4055-88FF-E6697002B931 wds:Q57571575-4628A096-AE32-402C-9BF4-9331B555EBF8 wds:Q57571575-50EE45FC-D689-4816-A689-BE0DBDEB9C74 wds:Q57571575-72BAE1C0-1567-4ED3-8BA5-6563F8D1201B wds:Q57571575-923737DB-585B-4CFE-9DA8-DF35D6397933 wds:Q57571575-A239B918-B98C-4EC4-A103-291BDA2D34FF wds:Q57571575-A2778E3D-46EE-43D4-B9C4-9F7ACEA9925C wds:Q57571575-B51C82EF-7491-43AC-8A36-7E4B9CB0E7DC wds:Q57571575-C385C5DD-3C6E-404F-8FC4-C548C5659D23 wds:Q57571575-D2627387-1A94-4C32-B31B-9B35A544057B wds:Q57571575-E1326B59-DCC7-483A-873B-41CB3A83B7B2
author name string	J W Oosterhuis J Verweij A van Oosterom I Judson C Hermans O S Nielsen M van Glabbeke H J Keizer A le Cesne Q van Hoesel L Svancárová K Krzemienlecki
rdfs:label	Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (en) Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (nl) Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (sq)
skos:prefLabel	Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (en) Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (nl) Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (sq)
name	Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (en) Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (nl) Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (sq)
author	wds:Q57571575-009DD893-CCE9-43F6-9CF4-3F1E485DF269 wds:Q57571575-026A6BF3-CBD6-47C8-935D-B57E8F72F053
author	John Radford Jean-Yves Blay
title	wds:Q57571575-2C2AF6C0-ACD0-49D0-9515-641347C5E5C5
title	Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (en)
page(s)	wds:Q57571575-1544269A-103F-4F5E-AE90-99D92CBDA16F
page(s)	61-67
instance of	wds:Q57571575-8B8DE245-52D1-4DF3-8BCD-7D0E102A58A6
instance of	scholarly article

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software